Possible Solutions as a Concept in Behavior Change Interventions

Mahoney, Diane E.

doi:10.1111/2047-3095.12210

Cited by 1 publication

(1 citation statement)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…While general MA intervention research has identified, compared, and improved health outcomes in other populations, women undergoing fertility treatment have not been the population of focus although background factors such as age, race, education, income, and health insurance status have influenced medication-taking behaviors in other patient populations (20-24). Thus, examining women’s perceptions about oral MA while taking fertility medications addresses an important knowledge gap in reproduction science research which is pivotal to determining if solutions are needed to assist women to overcome these behaviors ( 25 ). The purpose of this study was to identify women’s perceived barriers to and facilitators of oral MA during ovarian stimulation while documenting their medication-taking patterns.…”

Section: Introductionmentioning

confidence: 99%

Women’s Reports of Barriers to and Facilitators of Oral Medication Adherence During Ovarian Stimulation: A Mixed Methods Pilot Study

Mahoney¹,

Russell²

2021

JRI

View full text Add to dashboard Cite

Background: Adherence to lifestyle modification recommendations remains problematic for women undergoing fertility treatment, raising concerns about the extent to which women adhere to prescribed medication regimens. Limited data have shown suboptimal oral medication adherence rates of 19% to 74%. The objective of this study was to explore what women perceive as barriers to and facilitators of oral medication adherence during fertility treatment cycles. Methods: An exploratory mixed methods pilot study was conducted among a sample of 30 women who were actively taking one to two cycles of letrozole or clomiphene citrate for ovarian stimulation in conjunction with intrauterine insemination cycles. Medication adherence barriers were measured using a 20-item survey. Medication adherence facilitators and personal experiences with fertility treatment were assessed with structured interviews. Medication adherence was assessed with electronic event monitoring. Results: The overall medication adherence median was 0.97 with a range of 0.75 to 1.00, and nine women (50%) demonstrated perfect adherence. The most commonly reported barriers were recently feeling sad, down, or blue (53%), and taking medication more than once per day (40%). Women with higher barrier scores had significantly lower medication adherence scores (p=0.02) compared to women with lower total barrier scores. Facilitators included using physical aides as reminders (60%) and establishing a daily routine (50%). No significant correlation was found between medication adherence scores and facilitators. Conclusion: The dynamic interplay between perceived barriers and facilitators and women’s medication-taking patterns could influence whether or not medication regimens are followed correctly.

show abstract

Section: Introductionmentioning

confidence: 99%